Search

Search Constraints

You searched for: Author/Creator Coldman, Andrew

Search Results

1. O17.2 Women's experiences with primary human papillomavirus (HPV) testing for cervix screening: HPV focal exit survey results. (14th July 2019)

2. O17.1 HPV focal 48 month exit results by age for women HPV or LBC negative at baseline screening. (14th July 2019)

3. O17.3 Declining rates of cervical intraepithelial NEOPLASIA after introduction of the HPV vaccine in british columbia, canada. (14th July 2019)

4. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada. (June 2021)

6. Evaluation of the natural history of cancer of the cervix, implications for prevention. The Cancer Risk Management Model (CRMM) – Human papillomavirus and cervical components. (June 2015)

7. Simulating results from trials of sigmoidoscopy screening using the OncoSim microsimulation model. (March 2018)

8. Projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for Canada using the OncoSim microsimulation model. (September 2017)

9. Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval. (December 2016)